Davis Polk Advises on Placement of Shares in CSPC Pharmaceutical Group Limited

Davis Polk advised Morgan Stanley & Co. International plc in its capacity as placing agent for the placement of 500,000,000 shares in CSPC Pharmaceutical Group Limited (CSPC) for a total consideration of approximately HK$2,023 million.

CSPC is incorporated in Hong Kong with its shares listed on The Stock Exchange of Hong Kong Limited. It is primarily engaged in the manufacture and sale of pharmaceutical products.

The Davis Polk team included partners Paul Chow and James C. Lin and associates Peter Cheng, Shih-Jern Liang and Wilson Chan. All members of the Davis Polk team are based in the Hong Kong office.


Related Posts: